Survival and pathological response in pancreatic ductal adenocarcinoma after preoperative therapy with PD-1 blockade plus chemoradiotherapy followed by surgical resection

Background Neoadjuvant PD-1 blockade plus chemoradiotherapy has resulted in improved clinical response in pancreatic ductal adenocarcinoma (PDAC); however, the effects on pathological response (PR) and survival remain unknown. This study was to identify the survival and PR of patients with PDAC unde...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Elyar Abaydulla, Qi Li, Jialing Li, Defu Hu, Song Zhang, Shanshan Shen, Jian He, Aimei Li, Min Tang, Jun Chen, Huizi Sha, Liang Mao, Lei Wang, Juan Du, Yudong Qiu, Hao Cheng
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Taylor & Francis Group 2025-12-01
Schriftenreihe:	Annals of Medicine
Schlagworte:	Neoadjuvant therapy chemoradiotherapy immunotherapy pancreatic ductal adenocarcinoma complete pathological response survival
Online-Zugang:	https://www.tandfonline.com/doi/10.1080/07853890.2025.2541314
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!